Meridian Life Science Whitepapers
Benefits of multiplex testing for the differential diagnosis of COVID-19, Flu, and RSV in a busy flu season
This year’s winter season is anticipated to be a difficult one as experts warn of a “twindemic” with surges of both influenza and COVID-19 expected. The drop in seasonal temperature combined with people staying indoors traditionally creates a sharp increase in transmission of winter respiratory viruses such as flu and RSV. However, last year due to social distancing and mask-wearing policies, the flu season experienced a reprieve with historically low rates of influenza recorded. In contrast, this year as communities re-open and many of those policies are relaxed, experts predict large increases in transmission for COVID-19 and flu simultaneously. For a medical system that has already been under tremendous strain for the past 18 months, this news is concerning. Using tools such as multiplexing assays for flu, COVID, and RSV to diagnose and treat patients faster and more effectively becomes a necessary next step.
迈迪安提供全面解决方案
迈迪安为诊断制造商提供完整的解决方案,包括超过3000种抗原和抗体,涵盖500多种疾病,以及广泛的专业qPCR/RT-qPCR预混液和分子酶,所有产品均在符合ISO13485质控要求下生产。
Meridian搜索
与我们的专业团队联系
想了解更多迈迪安免疫和分子产品信息?欢迎与我们联系